PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 13 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Essential oil displayed inhibitory activities against xanthine oxidase, α-amylase, and α-glucosidase (IC50 values of 28.4, 130.6, and 59 respectively) [PMID:37636421]
Methanolic extracts and specific isolated compounds (e.g., piperlotine A, C, D, E) showed potent antiplatelet aggregation activity in rabbit models [PMID:17941696]
Evidence summary
PubMed sources
- 1.PMID: 37636421 (2023) — Xanthine oxidase, α-glucosidase and α-amylase inhibitory activities of the essential oil from Piper lolot: In vitro and in silico studies. · Heliyon
- 2.PMID: 17941696 (2007) — Isolation and identification of antiplatelet aggregatory principles from the leaves of Piper lolot. · Journal of agricultural and food chemistry